131 related articles for article (PubMed ID: 7138241)
1. Interrelationship between several prognostic factors in Hodgkin's disease.
Kotlarek-Haus S; Gabryś K; Starzyk H; Sciborski R; Gałazka Z
Arch Geschwulstforsch; 1982; 52(4):293-301. PubMed ID: 7138241
[TBL] [Abstract][Full Text] [Related]
2. [The significance of mediastinal involvement and other risk factors for survival in patients with Hodgkin's disease].
Melínova L; Hermanská Z; Halíková J; Dienstbier Z; Vacková B; Zámecník J; Skala E
Vnitr Lek; 1995 May; 41(5):307-12. PubMed ID: 7653060
[TBL] [Abstract][Full Text] [Related]
3. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients.
Brice P; Bastion Y; Divine M; Nedellec G; Ferrant A; Gabarre J; Reman O; Lepage E; Fermé C
Cancer; 1996 Sep; 78(6):1293-9. PubMed ID: 8826953
[TBL] [Abstract][Full Text] [Related]
4. [Long-term (over 10-years) survival in Hodgkin's disease].
Kotlarek-Haus S; Gabryś K; Kuliszkiewicz-Janus M; Potoczek S; Kiełbiński M
Acta Haematol Pol; 1993; 24(1):35-42. PubMed ID: 8488735
[TBL] [Abstract][Full Text] [Related]
5. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
6. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
Mjaaland I; Ganser D; Freitag EM; Bohndorf W
Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
[TBL] [Abstract][Full Text] [Related]
7. Patterns of Hodgkin's disease at diagnosis in young children.
White L; McCourt BA; Isaacs H; Siegel SE; Stowe SM; Higgins GR
Am J Pediatr Hematol Oncol; 1983; 5(3):251-7. PubMed ID: 6625107
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in Hodgkin's disease. I. Analysis of histopathology, stage distribution and results of therapy.
Björkholm M; Holm G; Mellstedt H; Johansson B; Askergren J; Söderberg G
Scand J Haematol; 1977 Nov; 19(5):487-95. PubMed ID: 594663
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in Hodgkin's disease: multivariate analysis of 327 patients from a single institution.
Smolewski P; Robak T; Krykowski E; Blasiñska-Morawiec M; Niewiadomska H; Pluzanska A; Chmielowska E; Zambrano O
Clin Cancer Res; 2000 Mar; 6(3):1150-60. PubMed ID: 10741746
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease.
Glavina-Durdov M; Jakic-Razumovic J; Capkun V; Murray P
Br J Cancer; 2001 May; 84(9):1227-34. PubMed ID: 11336475
[TBL] [Abstract][Full Text] [Related]
11. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
Urquhart A; Berg R
Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
[TBL] [Abstract][Full Text] [Related]
12. Lymphopenia: a bad prognostic factor in Hodgkin's disease.
Hancock BW; Dunsmore IR; Swan HT
Scand J Haematol; 1982 Sep; 29(3):193-9. PubMed ID: 7146822
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in Hodgkin's disease.
Dienstbier Z; Foltýnová V; Hermanská Z; Citavý M; Beska F; Cerný J; Hynek J; Koutná J; Machácek J; Zemanová E
Neoplasma; 1986; 33(6):731-5. PubMed ID: 3808128
[TBL] [Abstract][Full Text] [Related]
14. Hodgkin's disease and age.
Specht L; Nissen NI
Eur J Haematol; 1989 Aug; 43(2):127-35. PubMed ID: 2792320
[TBL] [Abstract][Full Text] [Related]
15. [Clinical results of 295 patients with Hodgkin's disease treated by chemotherapy-predominant comprehensive modality].
Huang HQ; Jiang WQ; Wang W; Xu GC; Zhang L; He YJ; Sun XF; Zhou ZM; Liu DG; Xu RH; Lin TY; Teng XY; Liu MZ; Su YS; Li YH; Lin XB; Guan ZZ
Ai Zheng; 2002 Dec; 21(12):1345-9. PubMed ID: 12520745
[TBL] [Abstract][Full Text] [Related]
16. HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma.
Diepstra A; van Imhoff GW; Karim-Kos HE; van den Berg A; te Meerman GJ; Niens M; Nolte IM; Bastiaannet E; Schaapveld M; Vellenga E; Poppema S
J Clin Oncol; 2007 Jul; 25(21):3101-8. PubMed ID: 17536082
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic factors concerning the survival time of Hodgkin's disease stage III and IV, treated with cytostatic agents].
Stoller U; Brunner K
Schweiz Med Wochenschr; 1976 Apr; 106(15):507-13. PubMed ID: 982004
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy.
Smith RS; Chen Q; Hudson MM; Link MP; Kun L; Weinstein H; Billett A; Marcus KJ; Tarbell NJ; Donaldson SS
J Clin Oncol; 2003 May; 21(10):2026-33. PubMed ID: 12743158
[TBL] [Abstract][Full Text] [Related]
19. Hodgkin's disease: a retrospective analysis of 15 years experience at a large referral centre.
Chandi L; Kumar L; Kochupillai V; Dawar R; Singh R
Natl Med J India; 1998; 11(5):212-7. PubMed ID: 10997167
[TBL] [Abstract][Full Text] [Related]
20. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]